DifGen Pharmaceuticals LLC has acquired Aveva Drug Delivery Services Inc., a developer and manufacturer of Transdermal Delivery Systems (TDS) and Oral Dissolvable Films (ODF). The transaction value was not disclosed in the provided information. The acquisition allows DifGen to expand its R&D and manufacturing capabilities, offering complex dosage forms and securing a local US-based supply for its partners. The move aims to provide affordable, high-quality, and consistent medication options to patients. Norton Rose Fulbright US LLP represented DifGen Pharmaceuticals in the transaction. Financial terms were not disclosed.